Scholars Central

Conference abstractPublished 28 Feb 2019

Anti-MRSA activity of cationic lipid carriers in combination with oxacillin for eradicating skin infection

Authors: Jia-You Fang

Chang Gung University, Taiwan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Nanoparticles have been the focus of being the antibacterial agents. The aim of this study was to evaluate the anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of cationic nanostructured lipid carriers (NLC) combined with oxacillin against ATCC 33591 and clinical isolate. The cationic resource on NLC surface was the decoration of soyaethyl morpholinium ethosulfate (SME). NLC loaded with oxacillin was produced to assess antibacterial activity and the topical application for treating cutaneous infection. The hydrodynamic diameter and zeta potential of oxacillin-loaded NLC were 177 nm and 19 mV, respectively. Oxacillin exhibited synergistic MRSA eradication when combined with NLC. The minimum bactericidal concentration (MBC) of oxacillin was decreased from 250 to 62.5 μg/ml after NLC encapsulation. The combined NLC and oxacillin reduced MRSA biofilm thickness from 31.2 to 13.0 μm, which was less than NLC (18.2 μm) and antibiotic (25.2 μm) alone. The oxacillin-loaded NLC showed a significant reduction in the burden of intracellular MRSA in differentiated THP-1 cells. This reduction was greater than that of individual treatment. The mechanistic study demonstrated the ability of cationic NLC to disrupt bacterial membrane, leading to the protein leakage. The cell surface disintegration also increased oxacillin delivery into the cytoplasm for activating the bactericidal process. Topical NLC treatment of MRSA abscess in skin decreased bacterial load by 4 logarithm and improved skin architecture and barrier function. Our results demonstrated that a combination of nanocarriers and an antibiotic could synergistically inhibit MRSA growth. It can be a potential approach to resolve the risk of drug resistance.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectDermatology
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Jia-You Fang”